SCHEMBL30387156

SCHEMBL30387156

Nc1cccc(-c2n[nH]c3ncnc(N)c23)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 9/20 0.59
PIK3CA P42336 9/20 0.59
PIK3CB P42338 9/20 0.59
PIK3CG P48736 9/20 0.59
PRKDC P78527 9/20 0.59
AURKA O14965 1/20 0.51
MAP4K4 O95819 3/20 0.47
ENPP2 Q13822 1/20 0.46
PDPK1 O15530 1/20 0.44
ABL1 P00519 1/20 0.42
EGFR P00533 1/20 0.42
CDK1 P06493 1/20 0.42
PRKCA P17252 1/20 0.42
PDE5A O76074 1/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE1C Q14123 1/20 0.40
PDE3A Q14432 1/20 0.40
LIMK1 P53667 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11405 0.85 PIK3CG (0.61) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30386858 0.85 PIK3CD (0.61) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL10855 0.85 MAP4K4 (0.49) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL408618 0.84 PIK3CD (0.55) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16665784 0.82 PIK3CD (0.55) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL21467047 0.82 FGFR1 (0.45) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL2243597 0.82 AURKA (0.46) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL145785 0.82 SRC (0.56) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL13825905 0.82 LRRK2 (0.45) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL15613551 0.82 LCK (0.52) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230111917-A1 KINASE ANTAGONISTS UNIV CALIFORNIA (US) 2023-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230111917-A1 KINASE ANTAGONISTS MTOR, RPS6KA3, AKT3 PIK3CD 12/4885PIK3CA 4/4885PIK3CB 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.